111
Views
2
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Marked Reduction in 28-day Mortality Among Elderly Patients with Severe Community-acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial

ORCID Icon, , , & ORCID Icon
Pages 2109-2115 | Published online: 09 Nov 2020

References

  • Brown RB. Community-acquired pneumonia: diagnosis and therapy of older adults. Geriatrics. 1993;48(2):43–50.8432435
  • Loeb MB. Community-acquired pneumonia in older people: the need for a broader perspective. J Am Geriatr Soc. 2003;51(4):539–543. doi:10.1046/j.1532-5415.2003.51165.x12657076
  • Neupane B, Walter SD, Krueger P, et al. Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study. BMC Geriatr. 2010;10(1):22. doi:10.1186/1471-2318-10-2220459844
  • Kelly E, MacRedmond RE, Cullen G, et al. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia? Respirology. 2009;14(2):210–216. doi:10.1111/j.1440-1843.2008.01423.x19272082
  • Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, et al. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med. 2009;103(2):309–316. doi:10.1016/j.rmed.2008.08.00618804355
  • Fung HB, Monteagudo-Chu MO. Community-acquired pneumonia in the elderly. Am J Geriatr Pharmacother. 2010;8(1):47–62. doi:10.1016/j.amjopharm.2010.01.00320226392
  • Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–72.17278083
  • Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–272. doi:10.1164/rccm.201504-0781OC26414292
  • Qi F, Liang ZX, She DY, et al. A clinical study on the effects and mechanism of xuebijing injection in severe pneumonia patients. J Tradit Chin Med. 2011;31(1):46–49.21563507
  • Li C, Wang P, Zhang L, et al. Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: a meta-analysis of randomized controlled trials. J Ethnopharmacol. 2018;224:512–521.29860133
  • Jiang M, Zhou M, Han Y, et al. Identification of NF-κB inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF. J Ethnopharmacol. 2013;147(2):426–433.23524166
  • Wang Q, Wu X, Tong X, et al. Xuebijing ameliorates sepsis-induced lung injury by downregulating HMGB1 and RAGE expressions in Mice. Evid Based Complement Alternat Med. 2015;2015(264):860259.25821501
  • Liu Y, Tian X, Cui M, et al. Safflower yellow inhibits angiotensin II-induced adventitial fibroblast proliferation and migration. J Pharmacol Sci. 2014;126(2):107.25231558
  • Song Y, Yao C, Yao Y, et al. XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial. Crit Care Med. 2019;47(9):e735–e743.31162191
  • Fine MJ, Smith DN, Singer DE. Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med. 1990;89(6):713–721. doi:10.1016/0002-9343(90)90211-U2252039
  • Marrie TJ, Haldane EV, Faulkner RS, et al. Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J Am Geriatr Soc. 1985;33(10):671–680.4045084
  • Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165(6):766–772.11897642
  • Rello J, Rodriguez R, Jubert P, et al. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study group for severe community-acquired pneumonia. Clin Infect Dis. 1996;23(4):723–728.8909834
  • Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797–808.29347874
  • Agbabiaka T, Wider B, Watson LK, et al. Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review protocol. Syst Rev. 2016;5(1):65. doi:10.1186/s13643-016-0244-227098011
  • Liu MW, Wang YH, Qian CY, Li H. Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis. Int J Mol Med. 2014;34(6):1492–504.25269519
  • Liu LW, Shi YY, Li ZL, Zuo LH, Sun Z. Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis. Front Pharmacol. 2020;11.31998136
  • Agbabiaka T, Wider B, Watson LK, Goodman C. Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review protocol. Syst Rev. 2016;5:65.27098011